Johnson & Johnson Agrees to Settle Five Risperdal Lawsuits
This article is for subscribers only.
Johnson & Johnson agreed to settle five lawsuits over claims that its antipsychotic drug Risperdal caused increased breast-tissue growth in boys.
Terms of the settlements weren’t disclosed at a hearing today in Philadelphia Court of Common Pleas.